Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • DESeq: question about baseMean. Also, replicates.

    One question about replicates in DESeq.

    I read "Analysing RNA-Seq with the DESeq package", version from April 21, 2011.

    In the "Quick Start" section of abovementioned document, they strongly advice to sum-up "purely technical" replicates and have only biological replicates in separate columns. However, in my experiment it's not clear to me if some of the replicates are "purely technical" or rather biological: I am analyzing different brain tissue samples in treated and untreated states. I have samples where the RNA-preparation has been done in duplicate from the same biological tissue, then sequenced independently. Is this to be considered technical or biological in the context of DESeq?
    Last edited by Azazel; 05-18-2011, 07:25 PM. Reason: Originally this post contained two unrelated questions about DESeq. I now split this into two. Answers below still in context

  • #2
    Originally posted by Azazel View Post

    2.) In the "Quick Start" section of abovementioned document, they strongly advice to sum-up "purely technical" replicates and have only biological replicates in separate columns. However, in my experiment it's not clear to me if some of the replicates are "purely technical" or rather biological: I am analyzing different brain tissue samples in treated and untreated states. I have samples where the RNA-preparation has been done in duplicate from the same biological tissue, then sequenced independently. Is this to be considered technical or biological in the context of DESeq?
    The answer to this shouldn't have anything to do with DESeq - it's the same issue regardless of the software used. I would say the answer lies in part of your question
    in duplicate from the same biological tissue
    To me it is then clear - this is a technical replicate and it would be wrong to classify those duplicate sample preps as independent biological replicate as they are from the same individual.

    Comment


    • #3
      I think maybe you could roughly look at the mean and var of each gene. If the var/mean is much higher than 1, then you may treat them as "bilogical rep"? And if the var/mean is around 1, you may treat them as "tech rep".. Since people saw technical reps are poisson distributed. And for biological reps, the var of the poisson is overdispersed.

      Comment


      • #4
        Originally posted by ning View Post
        I think maybe you could roughly look at the mean and var of each gene. If the var/mean is much higher than 1, then you may treat them as "bilogical rep"? And if the var/mean is around 1, you may treat them as "tech rep".. Since people saw technical reps are poisson distributed. And for biological reps, the var of the poisson is overdispersed.
        I'm not sure what the relationship between var and mean has to do with whether the samples are classified as biological or technical replicates. A biological replicate requires that the samples are independent. Extracting a second sample from the same individual will allow you to determine technical bias but it does not increase knowledge about how biologically reproducible a result it. Simon Andrews has posted some good answers in relation to this in other threads.

        Comment


        • #5
          Originally posted by natstreet View Post
          I'm not sure what the relationship between var and mean has to do with whether the samples are classified as biological or technical replicates. A biological replicate requires that the samples are independent. Extracting a second sample from the same individual will allow you to determine technical bias but it does not increase knowledge about how biologically reproducible a result it. Simon Andrews has posted some good answers in relation to this in other threads.
          Thanks for the comment!
          I'm just kind of thinking when we run DESeq or edgeR, both of them are assuming that different lanes follow a Negative Binomial distribution with the same "overdisperse parameter" corss all the lanes.
          If there are 4 lanes Lane1... Lane4. If Lane 1 and Lane2 are pure tech reps, then the "overdisperse parameter" of Lane1 and Lane2 will be small. But If we look at Lane1 vs Lane3 vs Lane4, the "overdisperse parameter" will be much larger. Then the "same overdisperse parameter" assumption won't hold if we analyze 4 lanes together. and the estimator of the overdisperse parameter will be pretty poor. That's why we need to sum-up "pure tech reps" in my understanding.
          So I'm thinking if we could observe the var of Lane1 and Lane2 is the same as the var of Lane1, Lane3, Lane4, I'll treat Lane1 and Lane2 as "Not-pure" technical reps since the "same overdisperse parameter" assumption holds. So I won't sum them up.
          Although maybe it's hard to get a good estimator of var if we only have two lanes...
          Does this make sense?

          Thanks

          Comment


          • #6
            A while ago, I've given a more comprehensive explanation of the rationale behind the treatment of technical replicates on the Bioconductor mailing lits. Maybe it is of interest in the current context:

            Comment

            Latest Articles

            Collapse

            • seqadmin
              Current Approaches to Protein Sequencing
              by seqadmin


              Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
              04-04-2024, 04:25 PM
            • seqadmin
              Strategies for Sequencing Challenging Samples
              by seqadmin


              Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
              03-22-2024, 06:39 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by seqadmin, 04-11-2024, 12:08 PM
            0 responses
            18 views
            0 likes
            Last Post seqadmin  
            Started by seqadmin, 04-10-2024, 10:19 PM
            0 responses
            22 views
            0 likes
            Last Post seqadmin  
            Started by seqadmin, 04-10-2024, 09:21 AM
            0 responses
            17 views
            0 likes
            Last Post seqadmin  
            Started by seqadmin, 04-04-2024, 09:00 AM
            0 responses
            49 views
            0 likes
            Last Post seqadmin  
            Working...
            X